Wijdenes J - Search Results

1

Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.

Klein B, Zhang XG, Jourdan M, Boiron JM, Portier M, Lu ZY, Wijdenes J, Brochier J, Bataille R. Klein B, et al. Among authors: wijdenes j. Eur Cytokine Netw. 1990 Oct-Nov;1(4):193-201. Eur Cytokine Netw. 1990. PMID: 2104241 Review.

2

A ciliary neurotrophic factor-sensitive human myeloma cell line.

Gu ZJ, Zhang XG, Hallet MM, Lu ZY, Wijdenes J, Rossi JF, Klein B. Gu ZJ, et al. Among authors: wijdenes j. Exp Hematol. 1996 Aug;24(10):1195-200. Exp Hematol. 1996. PMID: 8765494

3

Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop.

Gu ZJ, Costes V, Lu ZY, Zhang XG, Pitard V, Moreau JF, Bataille R, Wijdenes J, Rossi JF, Klein B. Gu ZJ, et al. Among authors: wijdenes j. Blood. 1996 Nov 15;88(10):3972-86. Blood. 1996. PMID: 8916964 Free article.

4

A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.

Rebouissou C, Wijdenes J, Autissier P, Tarte K, Costes V, Liautard J, Rossi JF, Brochier J, Klein B. Rebouissou C, et al. Among authors: wijdenes j. Blood. 1998 Jun 15;91(12):4727-37. Blood. 1998. PMID: 9616171 Free article.

5

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia.

Klein B, Wijdenes J, Zhang XG, Jourdan M, Boiron JM, Brochier J, Liautard J, Merlin M, Clement C, Morel-Fournier B, et al. Klein B, et al. Among authors: wijdenes j. Blood. 1991 Sep 1;78(5):1198-204. Blood. 1991. PMID: 1715218 Free article.

6

In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma.

Portier M, Rajzbaum G, Zhang XG, Attal M, Rusalen C, Wijdenes J, Mannoni P, Maraninchi D, Piechaczyk M, Bataille R, et al. Portier M, et al. Among authors: wijdenes j. Eur J Immunol. 1991 Jul;21(7):1759-62. doi: 10.1002/eji.1830210727. Eur J Immunol. 1991. PMID: 2060582

7

Measurement of whole body interleukin-6 (IL-6) production: prediction of the efficacy of anti-IL-6 treatments.

Lu ZY, Brailly H, Wijdenes J, Bataille R, Rossi JF, Klein B. Lu ZY, et al. Among authors: wijdenes j. Blood. 1995 Oct 15;86(8):3123-31. Blood. 1995. PMID: 7579407 Free article. Clinical Trial.

8

Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

Bataille R, Barlogie B, Lu ZY, Rossi JF, Lavabre-Bertrand T, Beck T, Wijdenes J, Brochier J, Klein B. Bataille R, et al. Among authors: wijdenes j. Blood. 1995 Jul 15;86(2):685-91. Blood. 1995. PMID: 7605999 Free article. Clinical Trial.

9

Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.

Lu ZY, Zhang XG, Rodriguez C, Wijdenes J, Gu ZJ, Morel-Fournier B, Harousseau JL, Bataille R, Rossi JF, Klein B. Lu ZY, et al. Among authors: wijdenes j. Blood. 1995 May 1;85(9):2521-7. Blood. 1995. PMID: 7727780 Free article.

10

Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6.

Legouffe E, Liautard J, Gaillard JP, Rossi JF, Wijdenes J, Bataille R, Klein B, Brochier J. Legouffe E, et al. Among authors: wijdenes j. Clin Exp Immunol. 1994 Nov;98(2):323-9. doi: 10.1111/j.1365-2249.1994.tb06145.x. Clin Exp Immunol. 1994. PMID: 7955540 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters